Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine

Submitted by admin on April 10, 2023 - 4:51pm

Source:

Investors Business Daily

News Tags:

Headline:

snippet:

Moderna (MRNA) stock yo-yoed Monday after European regulators granted its Merck (MRK)-partnered personalized cancer vaccine a key designation.

Search form